Gerresheimer AG buy philagent
Summary
This prediction ended on 26.02.14 with a price of €49.09. With a performance of -9.20%, the BUY prediction for Gerresheimer AG by philagent closed slightly in the red. philagent has 50% into this predictionGerresheimer is a German-based company that specializes in the production of high-quality glass and plastic packaging solutions for the healthcare industry. The company's products are used to store and transport medicines, vaccinations, and other healthcare products. With a global footprint, Gerresheimer operates in Europe, North America, South America, and Asia, serving leading pharmaceutical and life science companies. The company is publicly traded on the Frankfurt Stock Exchange and has a strong reputation for innovation, quality, and sustainability.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gerresheimer AG | -2.542% | -2.542% | 13.943% | 11.709% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by philagent for this prediction
In the thread Gerresheimer AG diskutieren
solide Zahlen – robuste Ergebnisse
Wenn Pharma boomt, boomt auch Gerresheimer. Spezialverpackungen aus Glas, Plastik und Pappe für Pharma, Medizin und Gesundheitswesen sorgt bei fast globaler Präsenz für steigende Umsatz- und Gewinnzahlen. Gerresheimer liefert robuste Ergebnisse, solide Zahlen trotz gering schrumpfender Margen aufgrund von Preiszugeständnissen, was in diesem Fall nur der andere Name für Mengenrabatte ist bei wachsendem Geschäft.